Your browser doesn't support javascript.
loading
Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers.
Fukushiro-Lopes, Daniela; Hegel, Alexandra D; Russo, Angela; Senyuk, Vitalyi; Liotta, Margaret; Beeson, Gyda C; Beeson, Craig C; Burdette, Joanna; Potkul, Ronald K; Gentile, Saverio.
Afiliación
  • Fukushiro-Lopes D; Department of Pharmacology, Loyola University Chicago, Maywood, IL, United States.
  • Hegel AD; Department of Pharmacology, Loyola University Chicago, Maywood, IL, United States.
  • Russo A; Department of Medicine, University of Illinois Chicago, Chicago, IL, United States.
  • Senyuk V; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, IL, United States.
  • Liotta M; Department of Medicine, University of Illinois Chicago, Chicago, IL, United States.
  • Beeson GC; Department of Gynecologic Oncology, Loyola University Chicago, Maywood, IL, United States.
  • Beeson CC; Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States.
  • Burdette J; Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States.
  • Potkul RK; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, IL, United States.
  • Gentile S; Department of Gynecologic Oncology, Loyola University Chicago, Maywood, IL, United States.
Front Pharmacol ; 11: 577, 2020.
Article en En | MEDLINE | ID: mdl-32457608

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos